CLINICAL_TRIALS
trial_result
· 2016-05-12
Clinical Trial Update: Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
A Phase 2 study of lenalidomide in previously untreated, symptomatic chronic lymphocytic leukemia was terminated. Results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Health Network, Toronto | Conditions: Chronic Lymphocytic Leukaemia | Phase 2 | Status: TERMINATED | Results posted: 2016-05-12